IHH Healthcare Bhd.

In the news

IHH Healthcare dragged down by goodwill impairment Jun 29, 2020
Bangkok virtual hospital finds opportunity in lockdown Jun 6, 2020
Singapore health tech mClinica to raise $20m as coronavirus spurs growth May 1, 2020
Asian stocks rebound as central banks pledge support to fight virus impact Mar 2, 2020
Asia businesses brace for virus amid China New Year exodus Jan 22, 2020

See more articles on IHH Healthcare Bhd.

Company Background

IHH Healthcare runs 37 private hospitals in 10 countries, including China and India. Its facilities have a total of more than 6,000 beds.

Headquartered in Malaysia, the company also sees Singapore and Turkey as its home markets. Its hospitals in these three countries attract affluent patients from across Southeast Asia and the Middle East. The group's Mount Elizabeth and Gleneagles hospitals in Singapore are considered particularly prestigious, thanks to their state-of-the-art medical equipment.

IHH is 44% owned by Khazanah Nasional, an investment arm of the Malaysian government. Khazanah in 2010 defeated a rival bid from India's Fortis Healthcare to take control of Parkway Holdings, a then-listed Singaporean company, which owned hospitals in Malaysia and Singapore. Today, Parkway is a wholly owned IHH subsidiary.

IHH is listed in both Malaysia and Singapore. The group is led by CEO Tan See Leng, who is also a doctor. Tan joined Parkway in 2004 and held various high-ranking positions before the company slid under IHH's umbrella.

Globally, IHH is the second-largest health care operator by market capitalization. Japanese trading house Mitsui & Co. is a major shareholder.

Business Summary

IHH Healthcare Bhd. operates as an investment holding company. The firm engages in the provision of healthcare services. It operates through the following geographical segments: Singapore, Malaysia, India, North Asia, Acibadem Holdings, IMU Health and PLife REIT. The company was founded on May 21, 2010 and is headquartered in Kuala Lumpur, Malaysia.

Financial Highlights

Dec 2019	MYR	USD
Revenue	14,912.48M	3,599.45M
Gross Profit	3,677.11M	887.55M
Operating income	1,685.73M	406.88M
Income before tax	968.61M	233.79M
Net income	463.30M	111.82M
EBITDA	3,041.22M	734.06M
Diluted EPS	0.05	0.01
Dividends Per Share	0.04	0.00
Total Assets	45,111.62M	11,028.38M
Total liabilities	19,175.82M	4,687.89M
Total equity	22,339.53M	5,461.32M
Operating cash flow	2,595.44M	626.46M
	Currency in MYR	Currency in USD

Historical Data

MYR | USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019
Revenue	8,455.46M	10,021.88M	11,142.63M	11,520.93M	14,912.48M
Gross Profit	2,327.18M	2,657.91M	2,620.19M	2,884.52M	3,677.11M
Operating income	1,210.55M	1,227.74M	1,068.88M	1,203.24M	1,685.73M
Income before tax	1,203.25M	860.94M	1,162.33M	739.05M	968.61M
Net income	933.90M	612.35M	931.31M	541.84M	463.30M
EBITDA	1,900.05M	2,026.87M	2,046.96M	2,142.40M	3,041.22M
Diluted EPS	0.11	0.07	0.11	0.06	0.05
Dividends Per Share	0.03	0.03	0.03	0.03	0.04
Total Assets	35,517.48M	37,200.39M	38,925.48M	45,020.85M	45,111.62M
Total liabilities	11,280.78M	13,307.23M	15,183.41M	18,827.09M	19,175.82M
Total equity	22,155.73M	21,985.74M	21,890.16M	21,994.00M	22,339.53M
Operating cash flow	1,863.97M	1,730.45M	2,006.03M	1,562.71M	2,595.44M

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019
Revenue	2,162.70M	2,419.15M	2,591.60M	2,854.98M	3,599.45M
Gross Profit	595.23M	641.58M	609.41M	714.80M	887.55M
Operating income	309.63M	296.36M	248.60M	298.17M	406.88M
Income before tax	307.76M	207.82M	270.34M	183.14M	233.79M
Net income	238.86M	147.81M	216.60M	134.27M	111.82M
EBITDA	485.98M	489.26M	476.09M	530.90M	734.06M
Diluted EPS	0.02	0.01	0.02	0.01	0.01
Dividends Per Share	0.00	0.00	0.00	0.00	0.00
Total Assets	8,272.38M	8,292.55M	9,618.35M	10,894.33M	11,028.38M
Total liabilities	2,627.40M	2,966.39M	3,751.77M	4,555.86M	4,687.89M
Total equity	5,160.29M	4,900.96M	5,408.98M	5,322.20M	5,461.32M
Operating cash flow	476.75M	417.70M	466.57M	387.25M	626.46M

Valuation Measures

Dec 2019
PER	103.59
ROA	1.02%
ROE	2.09%
Operating margin	11.30%
Profit margin	3.10%

Key executives

CEO, MD & Non-Independent Executive Director: Chi-Keon Loh
Group Chief Operating Officer: Sim Heng Joo Joe
Group Chief Financial Officer: Soon Teck Low
Group Head-Internal Audit: Audrey Huang
Vice President-Investor Relations: Penelope Koh

Shareholders

Mitsui & Co., Ltd. (32.9%)
Khazanah Nasional Bhd. (Investment Company) (26.0%)
Employees Provident Fund (8.6%)
Permodalan Nasional Bhd. (5.1%)
AYDINLAR MEHMET ALI (4.8%)
Kumpulan Wang Persaraan (3.0%)
Public Mutual Bhd. (1.7%)
Kuwait Investment Authority (Investment Management) (1.6%)
The Vanguard Group, Inc. (1.2%)
AYDINLAR FAMILY (1.1%)

Contact Details

Website:http://www.ihhhealthcare.com
Address: Level 11 Block A, Pantai Hospital, Kuala Lumpur, 8 Jalan Bukit Pantai, Kuala Lumpur, 59100, Malaysia
Phone: +60.3.2298.9898

Related Companies

Northern TK Venture Pte Ltd.
IHH Healthcare Bhd. (Singapore)
Centre For Digestive & Kidney Diseases India Pvt Ltd.
Acibadem Saglik Yatirimlari Holding AS
Indah Capital Ltd.
Shanghai Mai Kang Hospital Investment Management Co. Ltd.
Bodrum Tedavi Hizmetleri A.S
Integrated Healthcare Turkey Yatirimlari Ltd.
Gleneagles Development Pte Ltd.
Integrated Healthcare Holdings Ltd.
Acibadem Saglik Hizmetleri ve Ticaret AS
Pantai Holdings Sdn. Bhd.
Parkway Holdings Ltd.

Competitors

Last Updated on 6 Jul, 2020